Aspire-Lakewood Holdings ASBP
NASDAQ ASBP
$8.86 +0.01 (+0.11%)
As of: Oct 22, 2026 · 3:48 PM EDT

Aspire Biopharma Holdings, Inc. (ASBP) Accumulated Expenses (2025 - 2026)

Updated

Aspire Biopharma Holdings' Accumulated Expenses was $714,088 in Q2 2026, up 88.8% from $378,181 a year earlier and up 61.7% from the prior quarter.

Analysis

Aspire Biopharma Holdings, Inc. (ASBP) Accumulated Expenses (2025 - 2026) Analysis & Trends

At the end of FY2025, Accumulated Expenses at Aspire Biopharma Holdings came in at $1.01 million.

  • Quarterly Accumulated Expenses has moved between $266,930 (Q3 2025) and $1.01 million (Q4 2025) over five years.
  • Per Business Quant data, ASBP's Accumulated Expenses in the three quarters before Q2 2026 was $441,614 (Q1 2026), $1.01 million (Q4 2025) and $266,930 (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 714,088.00
Mar 31, 2026 441,614.00
Dec 31, 2025 1.01 Mn
Sep 30, 2025 266,930.00
Jun 30, 2025 378,181.00
Mar 31, 2025 319,067.00
API Access

Aspire Biopharma Holdings, Inc. Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ASBP&period=max&api_key=YOUR_API_KEY